Little Green PharmaASX:LGP -1.56% EV-to-FCF is -57.22 as of Jun. 29, 2026. The stock has 3 warning signs investors should review. Among 559 Drug Manufacturers companies, Little Green Pharma ranks worse than 178890.7% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Little Green Pharma's Enterprise Value is A$54.93 Mil.
Little Green Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was A$-0.96 Mil. Therefore, Little Green Pharma's EV-to-FCF for today is -57.22.
The historical rank and industry rank for Little Green Pharma's EV-to-FCF or its related term are showing as below:
ASX:LGP'
s EV-to-FCF Range Over the Past 10 Years
Min: -58.08 Med: -7.26 Max: 1.72
Current: -58.08
During the past 7 years, the highest EV-to-FCF of Little Green Pharma was 1.72. The lowest was -58.08. And the median was -7.26.
ASX:LGP's EV-to-FCF is ranked worse than 100% of 559
companies
in the Drug Manufacturers industry
Industry Median: 20.02
vs ASX:LGP: -58.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Little Green Pharma (ASX:LGP) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Little Green Pharma's PE Ratio (TTM) for today is calculated as:
Little Green Pharma's share price for today is A$0.063.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was A$-0.005.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Little Green Pharma EV-to-FCF Related Terms
Little Green Pharma EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Little Green Pharma's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's EV-to-FCF falls into.
Little Green Pharma's current Enterprise Value is A$54.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was A$-0.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) has a EV-to-FCF of -57.22 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Little Green Pharma and its competitors. According to the industry distribution chart, Little Green Pharma ranks #999999 out of 559 companies in the Drug Manufacturers industry.
Is Little Green Pharma's EV-to-FCF too high?
Little Green Pharma's current EV-to-FCF is -57.22. Based on the distribution chart, Little Green Pharma ranks #999999 out of 559 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Little Green Pharma's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Little Green Pharma ranks #999999 out of 559 companies for EV-to-FCF. This places Little Green Pharma in the lower half of its industry. The industry median EV-to-FCF is 20.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.02, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Little Green Pharma and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Little Green Pharma's current EV-to-FCF is -57.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 62.9% below its estimated fair value. The current EV-to-FCF is -57.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current EV-to-FCF is -57.22 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LGP has been successfully added to your 